News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
209 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39672)
2015 (44431)
2016 (38329)
2017 (37187)
2018 (39119)
2019 (51334)
2020 (57662)
2021 (58720)
2022 (53927)
2023 (42564)
2024 (37440)
2025 (33091)
2026 (28568)
Month
January (2434)
February (2869)
March (3030)
April (3117)
May (3356)
June (2726)
July (2287)
August (2491)
September (2814)
October (3178)
November (266)
Day
1 (180)
2 (176)
3 (166)
4 (36)
6 (28)
7 (20)
8 (209)
9 (212)
10 (153)
11 (45)
13 (31)
14 (133)
15 (141)
16 (97)
17 (129)
18 (39)
20 (21)
21 (93)
22 (125)
23 (160)
24 (113)
25 (42)
27 (22)
28 (135)
29 (163)
30 (145)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Month
January
February
March
April
May
June
July
August
September
October
November
Day
1
2
3
4
6
7
8
9
10
11
13
14
15
16
17
18
20
21
22
23
24
25
27
28
29
30
Press Releases
Clinical Science Update | New Clinical Evidence for ClotChek™
September 8, 2026
·
2 min read
Press Releases
ANSI Names R. Douglas Leonard Jr. Chief of Strategic Initiatives
September 8, 2026
·
4 min read
Press Releases
IBA – TRANSPARENCY NOTIFICATION - September 8, 2026
September 8, 2026
·
2 min read
Press Releases
AFT Pharmaceuticals partners with Mark Cuban Cost Plus Marketplace to bring the new non-opioid pain medication, Combogesic® to the U.S.
September 8, 2026
·
10 min read
Press Releases
Defence Therapeutics CEO Highlights Recent Progress and Outlines Strategic Priorities in Letter to Shareholders
September 8, 2026
·
8 min read
Press Releases
OS Therapies Achieves Statistically Significant Benefit for OST-HER2-Treated Patients in Interim 3-Year Overall Survival Analysis of Phase 2b Pulmonary Metastatic Osteosarcoma Trial
• 71.2% 3-year overall survival for OST-HER2-treated patients vs. 45.8% comparable combined historical control (p = 0.002) • The two remaining patients who have not yet reached the 3-year timepoint from enrollment have trial monitoring visits scheduled for September 2026 and early October 2026 • Company receives $3.15 million in VAT refunds into OS Therapies UK, Ltd. subsidiary, with an additional $7.2 million in refundable VAT and R&D Tax Credits pending
September 8, 2026
·
8 min read
Press Releases
Kiora Pharmaceuticals Appoints Keith J. Lane as Executive Vice President of Global Clinical Development and Regulatory Affairs
Clinical development executive brings over 20 years of ophthalmology experience supporting U.S. and global clinical trials to support the advancement of Kiora’s pipeline and new asset opportunities
September 8, 2026
·
2 min read
Press Releases
Maxwell Biosciences Receives FDA Qualified Infectious Disease Product (QIDP) Designation for All-Cause Bacterial and Fungal Pneumonia
September 8, 2026
·
4 min read
Press Releases
Leveragen Secures Australian Patent for Singularity Platform Advancing Fully Human Single-Domain Antibody Discovery
September 8, 2026
·
4 min read
Press Releases
Gilead Opens State-of-the-Art Research Center to Advance the Next Generation of Medicines
September 8, 2026
·
5 min read
Previous
18 of 21
Next
